Intraocular Pressure Elevation after Intravitreal Triamcinolone Acetonide Injection.
10.3341/kjo.2005.19.2.122
- Author:
Hye Young PARK
1
;
Kayoung YI
;
Ha Kyoung KIM
Author Information
1. Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea. ophkim@hallym.or.kr
- Publication Type:Original Article
- Keywords:
Intravitreal triamcinolone acetonide (IVTA) injection;
Intraocular pressure (IOP);
Younger age
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Female;
Glucocorticoids/*administration & dosage/*adverse effects/therapeutic use;
Humans;
Injections;
Intraocular Pressure/*drug effects;
Macular Edema, Cystoid/*drug therapy/*physiopathology;
Male;
Middle Aged;
Prospective Studies;
Triamcinolone Acetonide/*administration & dosage/*adverse;
Vitreous Body
- From:Korean Journal of Ophthalmology
2005;19(2):122-127
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: This study investigated firstly the change of intraocular pressure (IOP) after injection of intravitreal triamcinolone acetonide (IVTA) for the treatment of macular edema and secondly the factors that influence these changes. METHODS: A prospective, non-comparative study was performed in 60 patients at Kangnam Sacred Heart Hospital from October 2003 to September 2004. All the patients received 4-mg IVTA injection. RESULTS: Mean IOP was elevated from the day after injection and peaked at 20.5 mmHg after 2 months (p=0.000). Twenty-six eyes (43.3%) showed significant IOP elevation. IOP was not controlled despite full glaucoma medication in 7 (11.7%) eyes. Two eyes underwent filtering surgery. Younger age was a statistically significant predictive factor for IOP elevation (p=0.009). CONCLUSIONS: In this study, patients who needed filtering surgery developed an IOP spike within one week after the injection. Therefore, clinicians should consider checking IOP at the end of the first week. Furthermore, greater cautions is mandatory with relatively younger patients.
